TY - JOUR
T1 - Prognostic utility of cardiopulmonary exercise testing with simultaneous exercise echocardiography in heart failure with preserved ejection fraction
AU - Naito, Ayami
AU - Kagami, Kazuki
AU - Yuasa, Naoki
AU - Harada, Tomonari
AU - Sorimachi, Hidemi
AU - Murakami, Fumitaka
AU - Saito, Yuki
AU - Tani, Yuta
AU - Kato, Toshimitsu
AU - Wada, Naoki
AU - Adachi, Takeshi
AU - Ishii, Hideki
AU - Obokata, Masaru
N1 - Publisher Copyright:
© 2024 European Society of Cardiology.
PY - 2024/12
Y1 - 2024/12
N2 - Aims: Cardiopulmonary exercise testing (CPET) combined with exercise echocardiography (CPETecho) allows simultaneous assessments of cardiac, pulmonary, and ventilation in heart failure (HF) with preserved ejection fraction (HFpEF). This study sought to determine whether simultaneous assessment of CPET variables could provide additive predictive value over exercise stress echocardiography in patients with dyspnoea. Methods and results: CPETecho was performed in 443 patients with suspected HFpEF (240 HFpEF and 203 controls without HF). Patients with HFpEF were divided based on peak oxygen consumption (VO2, ≥10 or <10 ml/min/kg) or the slope of minute ventilation to carbon dioxide production (VE vs. VCO2 slope ≥45.0 or <45.0). The primary endpoint was defined as a composite of all-cause mortality, HF hospitalization, unplanned hospital visits requiring intravenous diuretics, or intensification of oral diuretics. During a median follow-up of 399 days, the composite outcome occurred in 57 patients. E/e' ratio during peak exercise was associated with adverse outcomes. Patients with HFpEF and lower peak VO2 had increased risks of the composite event (hazard ratio [HR] 5.05, 95% confidence interval [CI] 2.65–9.62, p < 0.0001 vs. controls; HR 3.14, 95% CI 1.69–5.84, p = 0.0003 vs. HFpEF with higher peak VO2). Elevated VE versus VCO2 slope was also associated with adverse events in HFpEF. The addition of either the presence of abnormal peak VO2 or VE versus VCO2 slope increased the predictive ability over the model based on age, sex, atrial fibrillation, left atrial volume index, and exercise E/e' (p < 0.05). Conclusion: These data provide new insights into the role of CPETecho in patients with HFpEF.
AB - Aims: Cardiopulmonary exercise testing (CPET) combined with exercise echocardiography (CPETecho) allows simultaneous assessments of cardiac, pulmonary, and ventilation in heart failure (HF) with preserved ejection fraction (HFpEF). This study sought to determine whether simultaneous assessment of CPET variables could provide additive predictive value over exercise stress echocardiography in patients with dyspnoea. Methods and results: CPETecho was performed in 443 patients with suspected HFpEF (240 HFpEF and 203 controls without HF). Patients with HFpEF were divided based on peak oxygen consumption (VO2, ≥10 or <10 ml/min/kg) or the slope of minute ventilation to carbon dioxide production (VE vs. VCO2 slope ≥45.0 or <45.0). The primary endpoint was defined as a composite of all-cause mortality, HF hospitalization, unplanned hospital visits requiring intravenous diuretics, or intensification of oral diuretics. During a median follow-up of 399 days, the composite outcome occurred in 57 patients. E/e' ratio during peak exercise was associated with adverse outcomes. Patients with HFpEF and lower peak VO2 had increased risks of the composite event (hazard ratio [HR] 5.05, 95% confidence interval [CI] 2.65–9.62, p < 0.0001 vs. controls; HR 3.14, 95% CI 1.69–5.84, p = 0.0003 vs. HFpEF with higher peak VO2). Elevated VE versus VCO2 slope was also associated with adverse events in HFpEF. The addition of either the presence of abnormal peak VO2 or VE versus VCO2 slope increased the predictive ability over the model based on age, sex, atrial fibrillation, left atrial volume index, and exercise E/e' (p < 0.05). Conclusion: These data provide new insights into the role of CPETecho in patients with HFpEF.
KW - Cardiopulmonary exercise testing
KW - Dyspnoea
KW - Exercise stress echocardiography
KW - Expired gas analysis
KW - Heart failure with preserved ejection fraction
UR - http://www.scopus.com/inward/record.url?scp=85195397995&partnerID=8YFLogxK
U2 - 10.1002/ejhf.3334
DO - 10.1002/ejhf.3334
M3 - Article
C2 - 38840564
AN - SCOPUS:85195397995
SN - 1388-9842
VL - 26
SP - 2582
EP - 2590
JO - European Journal of Heart Failure
JF - European Journal of Heart Failure
IS - 12
ER -